03.12.24 • Institut Imagine, Paris, France
Single-Cell Genomics 2024
Myllia is attending the Drug Discovery Forum Paris – Single Cell Genomics on December 3, 2024
Join Myllia in Paris and explore the latest research enabling single-cell genomics technologies and the impacts they are contributing in our understanding and treatment of disease. The maturation of single-cell technologies linked to CRISPR-based genetic perturbation at scale is making it increasingly possible to interrogate this heterogeneity and tease apart the resulting molecular mechanisms that drive disease phenotypes.
Event website:
Drug Discovery Forum in Paris 2024 – Single-Cell Genomics
Attendee(s):
Henrik Schmidt (LinkedIn)